Down-regulation of forkhead box protein M1 by siomycin A can inhibit the malignant behaviors of laryngeal carcinoma cells
10.16781/j.0258-879x.2016.08.0963
- Author:
Li-Zhu JIANG
1
Author Information
1. Department of Otolaryngology, The First Affiliated Hospital of Chongqing Medical University
- Publication Type:Journal Article
- Keywords:
Cell proliferation;
Forkhead box protein M1;
Laryngeal neoplasmas;
Neoplasm invasiveness;
Siomycin A
- From:
Academic Journal of Second Military Medical University
2016;37(8):963-968
- CountryChina
- Language:Chinese
-
Abstract:
Objective To investigate the effect of siomycin A-induced forkhead box protein M1(FoxM1) down-regulation on the malignant behaviors (proliferation, apoptosis, and invasive ability) of laryngeal carcinoma cells. Methods The experiment was performed with Hep-2cells of the logarithmic growth phase. The experimental groups were treated with different doses of siomycin A, and the control group was treated without siomycin A CCK-8 test was used to detect the viability of Hep-2 cells after treatment for 24, 48, and 72 h. CFSE staining was used to examine the proliferation ability of Hep-2 cells after treatment for 24 and 48 h. Annexin V_FITC/PI dual staining was used to observe the siomycin A-induced apoptosis and Transwell test was used to examine the invasion ability of Hep-2 cells after treatment for 48 h. The expressions of FoxM1, Ki-67 and cleaved caspase-3 protein inHep-2 cells were detected by Western blotting analysis. The supernatant levels of matrix metalloproteinase (MMP)-2 and MMP-9were examined by ELISA assay. Results (1) Treatment with siomycin A significantly decreased the expression of FoxM1 protein compared with the control group (P<0. 05). CCK-8 test found that siomycin A of different concentrations suppressed the viability of Hep-2 cells in a time- and dose-dependent manner. (2) Siomycin A at 1. 3 and 1. 5 µmol/L significantly suppressed the proliferation of Hep-2 cells in a dose-dependent manner (P<0. 05), accompanied by down-regulated expression of Ki-67. (3) Siomycin A at 1. 3 and 1. 5 µmol/L also induced greater apoptosis of Hep-2 cells (10. 6%, 27. 9%) in a dose-dependent manner compared with control group (4. 91%, P<0. 05), accompanied by up-regulated cleaved caspase-3 expression. (4) Siomycin A at 1.3 and 1. 5 µmol/L suppressed the invasive ability of Hep-2 cells in a dose-dependent manner compared with control group (P < 0. 05), accompanied by down-regulated expression of MMP-2 and MMP-9. Conclusion Down-regulation of FoxM1 by siomycin A can inhibit the proliferation and invasive ability of laryngeal carcinoma cells.
